Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | P-CD19CD20-ALLO1 |
Synonyms | |
Therapy Description |
P-CD19CD20-ALLO1 are allogeneic T stem cell-rich T-lymphocytes engineered to express chimeric antigen receptors (CARs) targeting CD19 and CD20, which potentially induces antitumor activity against CD19 and CD20-expressing tumor cells (Blood (2024) 144 (Supplement 1): 4805). |